TreeFrog Therapeutics receives additional €3M non-dilutive funding to mass-produce clinical-grade cell therapies by 2021 Company awarded close to €3M ($3.3M) in public grants only five months after Series A round of €7M ($7.8M) Bordeaux, France, September 5, 2019 – TreeFrog Therapeutics, an expert stem cell company, today announces...
TreeFrog will be in Japan from the 10th to 21th of September 2019 to meet key academic and industry players ! This cell therapy roadtrip, organized with the help of Business France, will be marked by our participation to Cell Therapy Word Asia 2019 on Sept 18-19 !...
Kevin Alessandri, CEO/CTO of TreeFrog was cited in a recent article of Labiotech.eu on the current obstacles preventing cell therapies to become mainstream. Read more...
Read the article here...
TreeFrog Therapeutics raises over €7M ($7.8M) in Series A financing round 6 months after incorporationFunding to scale-up company’s proprietary technology C-Stem™ for mass-production of safe and affordable cell therapiesBordeaux, France, May 13, 2019 – TreeFrog Therapeutics, an expert stem cell company, today announces that it has...
We will be at booth P8 ! Let’s discuss cell therapy mass production there !Learn about the event...
C- Stem™ technology introduces a new standard for hIPS suspension culture. Based on biomimetic stem cell culture in 3D, C- Stem™ enables cell therapy production scale-up while ensuring genomic and phenotypic stability Bordeaux, France, April 16, 2019 – TreeFrog Therapeutics, an expert stem cell company, today announces that...
https://youtu.be/L3FxGlLKVsM This new explainer video provides a quick overview of C-Stem™, the patented technology operated by TreeFrog Therapeutics to mass-produce stem cells for cell therapy....
https://youtu.be/b7y8YHiqlNI“Four months after its creation, TreeFrog Therapeutic announces license agreement with tech transfer office Aquitaine Science Transfert to industrialize and commercialize a breakthrough technology based on 3D cell culture. Newly headquartered at the ENSTBB, on the campus of Bordeaux, the start-up aims at providing the pharmaceutical industry with...